Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man.
Open Access
- 1 October 1984
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 18 (4) , 507-521
- https://doi.org/10.1111/j.1365-2125.1984.tb02498.x
Abstract
Interindividual variation in the sulphoxidation of S-carboxymethyl-L- cysteine (750 mg p.o.) was investigated in 200 healthy volunteers. Nearly a 100-fold difference was observed between individuals with respect to the amount of sulphoxide metabolites detected in their 0-8 h urine (0.6 to 59.1% recovery). Such a difference was shown to be reproducible over several months in 40 subjects who spanned the entire range of capacities. Cumulative plots and maximum likelihood analysis of the distribution indicated that a bimodal model was most probable. Analysis of pedigree data obtained from 12 families suggested a genetic effect with overlying environmental influences.Keywords
This publication has 35 references indexed in Scilit:
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- DEFICIENT SULPHOXIDATION STATUS AND D-PENICILLAMINE TOXICITYThe Lancet, 1983
- Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic VariationsClinical Pharmacokinetics, 1983
- GENETICALLY DETERMINED IMPAIRED DRUG SULPHOXIDATIONThe Lancet, 1981
- Excretion and Biotransformation of Carboxymethyl-cysteine in Rat, Dog, Monkey and ManXenobiotica, 1978
- The Metabolism ofS-Carboxymethylcysteine in Rodents, Marmosets and HumansXenobiotica, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Assay Procedures for Thioridazine, Trifluoperazine, and Their Sulfoxides and Determination of Urinary Excretion of These Compounds in Mental PatientsJournal of Pharmaceutical Sciences, 1974
- One cause? Many causes?Journal of Chronic Diseases, 1964